The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome. Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages are major risk factors for development of NAFLD. Today the most commonly consumed sugar is high fructose corn syrup. Hepatic lipids may be derived from dietary intake, esterification of plasma free fatty acids (FFA) or hepatic de novo lipogenesis (DNL). A central abnormality in NAFLD is enhanced DNL. Hepatic DNL is increased in individuals with NAFLD, while the contribution of dietary fat and plasma FFA to hepatic lipids is not significantly altered. The importance of DNL in NAFLD is further established in mouse studies with knockout of genes involved in this process. Dietary fructose increases levels of enzymes involved in DNL even more strongly than HFD. Several properties of fructose metabolism make it particularly lipogenic. Fructose is absorbed via portal vein and delivered to the liver in much higher concentrations as compared to other tissues. Fructose increases protein levels of all DNL enzymes during its conversion into triglycerides. Additionally, fructose supports lipogenesis in the setting of insulin resistance as fructose does not require insulin for its metabolism, and it directly stimulates SREBP1c, a major transcriptional regulator of DNL. Fructose also leads to ATP depletion and suppression of mitochondrial fatty acid oxidation, resulting in increased production of reactive oxygen species. Furthermore, fructose promotes ER stress and uric acid formation, additional insulin independent pathways leading to DNL. In summary, fructose metabolism supports DNL more strongly than HFD and hepatic DNL is a central abnormality in NAFLD. Disrupting fructose metabolism in the liver may provide a new therapeutic option for the treatment of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Patients with MASLD often show reduced hepatic ATP [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Importantly, DAG buildup, not TG, is linked to hepatic IR via PKC activation.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Sontrop, J. M., Dixon, S. N., Garg, A. X., Jiménez, I. B., Dohein, O., Huang, S. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,903
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Self-citationTriglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,732
Insulin Receptor Signaling in Normal and Insulin-Resistant StatesPreprint
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,550
Self-citation
Cited by
Sorted by citations
Items 301–400 of 705
Mazzoli, A., Gatto, C., Crescenzo, R., Cigliano, L., & Iossa, S. (2021) · Nutrients · doi:10.3390/nu13041370 · Cited by 15
Correa‐Rodríguez, M., Pocovi-Gerardino, G., Callejas-Rubio, J. L., Ríos-Fernández, R., Martín-Amada, M., Cruz-Caparrós, M.-G., Medina-Martínez, I., Ortego‐Centeno, N., & Rueda‐Medina, B. (2020) · Nutrients · doi:10.3390/nu12041094 · Cited by 17
Tao, S.-H., Lei, Y., Tan, Y., Yang, Y.-B., & Xie, W. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1476419 · Cited by 16
Arellano-García, L., Portillo, M. P., Martínez, J. A., Courtois, A., & Milton‐Laskibar, I. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2437143 · Cited by 15
A high sucrose diet modifies brain oxylipins in a sex-dependent manner
Norman, J., Nuthikattu, S., Milenković, D., Rutledge, J. C., & Villablanca, A. C. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102506 · Cited by 14
Voilquin, L., Liu, T., Jung, Y., Taylor, N. P., Zhao, M., Charville, G. W., Nissen, S. B., Yki‐Järvinen, H., Altman, R. B., & Svensson, K. J. (2022) · iScience · doi:10.1016/j.isci.2022.105802 · Cited by 16
Kakimoto, M., Fujii, M., Sato, I., Honma, K., Nakayama, H., Kirihara, S., Fukuoka, T., Ran, S., Hirohata, S., Kitamori, K., et al. (2023) · Journal of Applied Biomedicine · doi:10.32725/jab.2023.009 · Cited by 14
Syed‐Abdul, M. M., Moore, M. P., Wheeler, A. A., Ganga, R., Diaz‐Arias, A. A., Petroski, G. F., Rector, R. S., Ibdah, J. A., & Parks, E. J. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.09.018 · Cited by 15
Briansó‐Llort, L., Sáez‐López, C., Álvarez-Guaita, A., Ramos‐Perez, L., Hernández, C., Simó, R., & Selva, D. M. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400020 · Cited by 15
Janssens, S., Čiapaitė, J., Wolters, J. C., van Riel, N. A. W., Nicolay, K., & Prompers, J. J. (2017) · Nutrients · doi:10.3390/nu9050476 · Cited by 16
Mukonowenzou, N., Dangarembizi, R., Chivandi, E., Nkomozepi, P., & Erlwanger, K. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420000124 · Cited by 12
Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD
Sahoo, S., Singh, D., Chakraborty, P., & Jolly, M. K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030870 · Cited by 14
Two weeks of western diet disrupts liver molecular markers of cholesterol metabolism in rats
St-Amand, R., Sock, E. T. N., Quinn, S., Lavoie, J.-M., & St-Pierre, D. H. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01351-2 · Cited by 14
Radulescu, A., Dugan, A. J., Killian, M., Attia, S. L., Mouzaki, M., Fuchs, G. J., Kohli, R., Bada, H. S., Kern, P. A., & Softic, S. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12862 · Cited by 12
Self-citationFollistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
Tong, J., Cong, L., Jia, Y., He, A. B.-L., Guo, Y., He, J., Li, D., Zou, B., & Li, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s380053 · Cited by 15
Molecular Mechanisms of Cell Death
Lemasters, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00001-8 · Cited by 14
Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases
Guimarães, R. C., Gonçalves, T. T., & Leiria, L. O. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15321 · Cited by 15
Capra, M. E., Biasucci, G., Banderali, G., & Pederiva, C. (2023) · Nutrients · doi:10.3390/nu15051088 · Cited by 13
LncRNA Gm35585 transcriptionally activates the peroxidase EHHADH against diet-induced fatty liver
Jin, M., Lü, Q., Xia, N., Fan, X., Zhang, Z., Huang, X., Sun, L., Zhang, L., Jiang, Z., & Yu, Q. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01420-5 · Cited by 13
Nagy, J., & Kovács, T. (2019) · Physiology International · doi:10.1556/2060.106.2019.35 · Cited by 13
Targeting hepatocyte carbohydrate transport to mimic fasting and calorie restriction
Kading, J. C., Finck, B. N., & DeBosch, B. J. (2020) · FEBS Journal · doi:10.1111/febs.15482 · Cited by 13
Moghadam, S. D., Navarro, S. L., Shojaie, A., Randolph, T. W., Bettcher, L., Le, C., Hullar, M. A. J., Kratz, M., Neuhouser, M. L., Lampe, P. D., et al. (2020) · Metabolomics · doi:10.1007/s11306-020-01746-3 · Cited by 13
Exploring diet associations with Covid-19 and other diseases: a Network Analysis–based approach
Toor, R., & Chana, I. (2022) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-022-02505-3 · Cited by 13
Zhang, C., Lu, Y., Song, Y., Chen, L., Hu, J., Meng, Y., Chen, X., Li, S., Zheng, G., & Qiu, Z. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17435 · Cited by 13
Zani, S. C. D. C., Wang, R., Veida-Silva, H., Clugston, R. D., Yue, J. T. Y., Mori, M. A. S., Wu, J., & Chan, C. B. (2023) · Metabolites · doi:10.3390/metabo13020174 · Cited by 14
Chen, Q., Ren, R., Sun, Y., Xu, J., Yang, H., Li, X., Xiao, Y., Li, J., & Lyu, W. (2023) · Food & Function · doi:10.1039/d3fo02246c · Cited by 13
Ectopic fat: a target for cardiometabolic risk management
Gastaldelli, A., & Gaggini, M. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1256773 · Cited by 13
Murayama, H., Eguchi, A., Nakamura, M., Kawashima, M., Nagahara, R., Mizukami, S., Kimura, M., Makino, E., Takahashi, N., Ohtsuka, R., et al. (2018) · Toxicologic Pathology · doi:10.1177/0192623318778508 · Cited by 13
Domingues, I., Yagoubi, H., Zhang, W., Marotti, V., Kambale, E. K., Vints, K., Śliwińska, M. A., Leclercq, I. A., & Beloqui, A. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01576-z · Cited by 14
Zhang, D., Zhao, Y., Zhang, G., Lank, D. S., Cooke, S., Wang, S., Nuotio-Antar, A. M., Tong, X., & Yin, L. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101957 · Cited by 12
Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery
Herrera-Marcos, L. V., Arbonés-Mainar, J. M., & Osada, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158285 · Cited by 12
Islam, M. A., Khairnar, R., Fleishman, J. S., Reznik, S. E., Ragolia, L., Gobbooru, S., & Kumar, S. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112404 · Cited by 12
Xu, Y., Zhang, Y., Sun, W., Tang, Q., Feng, W., Xiao, H., Wang, J., Yuan, X., Xiang, M., Gao, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-87871-2 · Cited by 14
Gonzalez‐Vicente, A., Garvin, J. L., & Hopfer, U. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201293 · Cited by 12
Effect of Wakame and Carob Pod Snacks on Non-Alcoholic Fatty Liver Disease
Rico, D., Martín‐Diana, A. B., Lasa, A., Aguirre, L., Milton‐Laskibar, I., de Luis, D. A., & Miranda, J. (2019) · Nutrients · doi:10.3390/nu11010086 · Cited by 12
Subramaniam, A., Landstrom, M., & Hayes, K. C. (2019) · Nutrients · doi:10.3390/nu11071538 · Cited by 12
Long, N. E. D., Hardy, D. B., Ma, N., & Holloway, A. C. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3502 · Cited by 12
Milton‐Laskibar, I., Marcos-Zambrano, L. J., Gómez‐Zorita, S., Pau, E. C. D. S., Fernández‐Quintela, A., Martínez, J. A., & Portillo, M. P. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.2 · Cited by 10
Gut Microbes and Circulating Cytokines in Preterm Infants with Growth Failure
Strobel, K. M., Vecchio, G. D., Devaskar, S. U., & Calkins, K. L. (2022) · Journal of Nutrition · doi:10.1016/j.tjnut.2022.10.005 · Cited by 12
Food Insecurity and Pediatric Nonalcoholic Fatty Liver Disease Severity
Orkin, S. H., Zhao, X., Setchell, K. D. R., Carr, E., Arce‐Clachar, A. C., Bramlage, K., Huang, R., Fei, L., Beck, A. F., Fawaz, R. L., et al. (2023) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2023.113818 · Cited by 12
Wang, K., Shi, M., Luk, A. O. Y., Kong, A. P. S., Ronald, C. W., Li, C., Chen, L., Chow, E., & Chan, J. C. N. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02321-z · Cited by 12
Macronutrient interactions and models of obesity: Insights from nutritional geometry
Wali, J. A., Ni, D., Raubenheimer, D., & Simpson, S. J. (2024) · BioEssays · doi:10.1002/bies.202400071 · Cited by 11
The role of dietary sugars in cancer risk: A comprehensive review of current evidence
Hasan, N., Yazdanpanah, O., Khaleghi, B., Benjamin, D. J., & Kalebasty, A. R. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.100876 · Cited by 13
Emerging Roles of Periodontal Pathogen–Derived Outer Membrane Vesicles in NAFLD
Lv, C., Shi, K., Guo, Y.-D., Guo, Z., Luo, P., Wang, L., Wu, Z., & Yu, P. L. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.03.029 · Cited by 11
Fructose Metabolism in Cancer: Molecular Mechanisms and Therapeutic Implications
Chen, X., Yang, M., Wang, L., Tu, J., & Yuan, X. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.108549 · Cited by 11
Byun, K.-A., Oh, S., Son, M., Park, C.-H., Son, K. H., & Byun, K. (2021) · Marine Drugs · doi:10.3390/md19090495 · Cited by 10
Kashiwazaki, G., Watanabe, R., Nishikawa, A., Kawamura, K., Kitayama, T., & Hibi, T. (2022) · RSC Advances · doi:10.1039/d2ra01569b · Cited by 11
Cincotta, A. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713255 · Cited by 11
Dietary Patterns, Foods, Nutrients and Phytochemicals in Non-Alcoholic Fatty Liver Disease
Dreher, M. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-59180-3_10 · Cited by 11
Fahlbusch, P., Nikolic, A., Hartwig, S., Jacob, S., Kettel, U., Koellmer, C., Al‐Hasani, H., Lehr, S., Müller‐Wieland, D., Knebel, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126873 · Cited by 11
Santos, H. O., & Penha-Silva, N. (2025) · Nutrition · doi:10.1016/j.nut.2024.112617 · Cited by 11
Al‐Busafi, S. A., Alwassief, A., Madian, A., Atalla, H., Alboraie, M. A. A., Elbahrawy, A., & Eslam, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i8.108730 · Cited by 10
Degrave, V. M., Joubert, M. B. V., Ingaramo, P. I., Sedán, D., Andrinolo, D., D’Alessandro, M. E., & Oliva, M. E. (2023) · Medical Cannabis and Cannabinoids · doi:10.1159/000534610 · Cited by 11
Liu, Z., Huang, H., Xie, J., Hou, L., & Xu, C. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00897-y · Cited by 10
Reis-Costa, A., Belew, G. D., Viegas, I., Tavares, L. C., Meneses, M. J., Patrício, B. G., Gastaldelli, A., Macedo, M. P., & Jones, J. G. (2024) · Nutrients · doi:10.3390/nu16142186 · Cited by 13
Relationship between Abnormal Lipid Metabolism and Gallstone Formation
Li, X., Yin, X., Xu, J., Geng, L., & Liu, Z. (2025) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.135 · Cited by 10
Bhattacharya, I., Maity, D. K., Kumar, A., Sarkar, S., Bhattacharya, T., Sahu, A., Sreedhar, R., & Arumugam, S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04257-x · Cited by 11
Akinnuga, A. M., Siboto, A., Khumalo, B., Sibiya, N. H., Ngubane, P. S., & Khathi, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2978340 · Cited by 9
Fattore, E., Botta, F., & Bosetti, C. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa077 · Cited by 10
Gao, R., Zhang, X., Zhou, Z., Sun, J., Tang, X., Li, J., Zhou, X., & Shen, T. (2022) · Disease Markers · doi:10.1155/2022/7251450 · Cited by 10
The effects of the voglibose on non-alcoholic fatty liver disease in mice model
Bae, J., Lee, J. Y., Shin, E., Lee, M., Lee, Y., Lee, B., Kang, E. S., & Soo, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-15550-7 · Cited by 10
Gomes, H. M., Silveira, A. K., Gasparotto, J., Bortolin, R. C., Terra, S. R., Brum, P. O., Gelain, D. P., & Moreira, J. C. F. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109272 · Cited by 10
Méndez, L., Muñoz, S., Barros, L., Miralles‐Pérez, B., Romeu, M., Ramos‐Romero, S., Torres, J. L., & Medina, I. (2023) · Antioxidants · doi:10.3390/antiox12030751 · Cited by 10
Effects of metabolic syndrome on jawbones and bone metabolic markers in sucrose-fed rats
TÜKEL, H. C., & DELİLBAŞI, E. A. (2019) · Odontology · doi:10.1007/s10266-019-00422-w · Cited by 10
Kattapuram, N., Zhang, C., Muyyarikkandy, M. S., Surugihalli, C., Muralidaran, V., Gregory, T., & Sunny, N. E. (2021) · Metabolites · doi:10.3390/metabo11050272 · Cited by 10
Ashraf, S., Ashraf, N., Yilmaz, G., & Harmancey, R. (2021) · Physiological Reports · doi:10.14814/phy2.14958 · Cited by 10
Park, S., Helsley, R. N., Noetzli, L. J., Tu, H.-C., Wallenius, K., O’Mahony, G., Boucher, J., Liu, J., & Softic, S. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100731 · Cited by 10
Self-citationRadulescu, A., Killian, M., Kang, Q., Yuan, Q., & Softic, S. (2022) · Nutrients · doi:10.3390/nu14071500 · Cited by 15
Self-citationGuava Leaf Extract Suppresses Fructose Mediated Non-Alcoholic Fatty Liver Disease in Growing Rats
Sharma, P., Nair, J., Sinh, A., Shivangi, Velpandian, T., Tripathi, R., & Mathur, R. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s381102 · Cited by 10
Li, F., Cousineau, C., Xing, G., Raha, N., Clemens, S. L., Mofikoya, M., Kim, M.-Y., & Zhang, J. Y. (2019) · Bioanalysis · doi:10.4155/bio-2018-0286 · Cited by 10
Fuller, S. E., Yu, Y., Allerton, T. D., Mendoza, T. M., Ribnicky, D., & Floyd, Z. E. (2020) · Nutrients · doi:10.3390/nu12082233 · Cited by 9
Taurine alleviated hepatic steatosis in oleic acid-treated-HepG2 cells and rats fed a high-fat diet
Song, Q., Guo, J., Xun, Y. F., Ou, T., Zhang, J., Li, H. Z., Mi, S., Zhang, Y. Z., Oda, H., & Chen, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16401 · Cited by 9
Parsa, A. A., Azama, K. A., Vawer, M., Ona, M. A., & Seto, T. B. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad165 · Cited by 9
Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells
Li, L., Zhang, X., Xu, G., Xue, R., Li, S., Wu, S., Yang, Y., Lin, Y., Lin, J., Liu, G., et al. (2024) · Advanced Science · doi:10.1002/advs.202404229 · Cited by 9
Hart, T. L., Kris‐Etherton, P. M., & Petersen, K. S. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.01.024 · Cited by 9
Role of natural compounds in non-alcoholic fatty liver diseases (NAFLD): a mechanistic approach
Wal, P., Yadav, S., Jha, S. K., Singh, A., Bhargavi, B., Shivaram, R., Imran, M., & Aziz, N. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00452-w · Cited by 11
Park, J. Y., Jang, M. G., Oh, J. M., Ko, H., Hur, S., Kim, J.-W., Baek, S., & Kim, S. (2020) · Nutrients · doi:10.3390/nu12123762 · Cited by 9
Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae
Damen, M. S. M. A., Stankiewicz, T. E., Park, S., Helsley, R. N., Chan, C. C., Moreno‐Fernandez, M. E., Doll, J., Szabo, S., Herbert, D. R., Softic, S., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00902-6 · Cited by 9
Self-citationFructose in the diet expands the surface of the gut and promotes nutrient absorption
Nunes, P. M., & Anastasiou, D. (2021) · Nature · doi:10.1038/d41586-021-02195-1 · Cited by 9
Harder, N. H. O., Lee, H. P., Flood, V. J., Juan, J. A. S., Gillette, S. K., & Heffern, M. C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.863296 · Cited by 9
TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases
Kim, J. E., Kim, E.-M., & Lee, S. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158387 · Cited by 9
Shi, H., Prough, R. A., McClain, C. J., & Song, M. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109189 · Cited by 9
Zhang, F., Pei, J., & Chen, X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.049 · Cited by 9
Smith, E. V. L., Dyson, R. M., Vanderboor, C., Sarr, O., Anderson, J., Berry, M. J., Regnault, T. R. H., Peng, L., & Gray, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020999 · Cited by 11
Du, J., Shen, M., Chen, J., Yan, H., Xu, Z., Yang, X., Yang, B., Luo, P., Ding, K., Hu, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1510080 · Cited by 9
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
Lucaciu, R. L., Coste, S. C., Hangan, A. C., Iancu, M., Orasan, O. H., Cozma, A., Bogdan, S. G., & Procopciuc, L. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125717 · Cited by 11
ANGPTL3 orchestrates hepatic fructose sensing and metabolism
Zhao, M., Linde-Garelli, K. Y., Zhang, Z., Toomer, D. J., Reghupaty, S. C., Jimenez, J. I., Voilquin, L., Wat, L. W., Fernández, D., & Svensson, K. J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115962 · Cited by 9
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
Weiskirchen, R., & Lonardo, A. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671694 · Cited by 9
Variation in Infant Formula Macronutrient Ingredients Is Associated with Infant Anthropometrics
Young, B. E. (2020) · Nutrients · doi:10.3390/nu12113465 · Cited by 8
Zhang, D., Wang, S., Ospina, E., Shabandri, O., Lank, D. S., Akakpo, J. Y., Zhao, Z., Yang, M., Wu, J., Jaeschke, H., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1683 · Cited by 8
Feeding of a fat‐enriched diet causes the loss of resistance to contact hypersensitivity
Rühl‐Muth, A., Maler, M. D., Esser, P. R., & Martin, S. F. (2021) · Contact Dermatitis · doi:10.1111/cod.13927 · Cited by 9
Quan, X., Guo, Q., Li, X., Yu, L., Cui, M., Li, J., Huang, S., Wang, J., & Li, B. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14134 · Cited by 8
Nonalcoholic Steatohepatitis in Children
Xanthakos, S. A. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.05.001 · Cited by 8
Slusher, A. L., Hu, P., Samuels, S. L., Tokoglu, F., Lat, J., Li, Z., ALGUARD, M. D., Strober, J. W., Vatner, D. F., Shabanova, V., et al. (2023) · Obesity · doi:10.1002/oby.23728 · Cited by 10
Danoy, M., Poulain, S., Jellali, R., Gilard, F., Kato, S., Plessy, C., Kido, T., Miyajima, A., Sakai, Y., & Leclerc, É. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107490 · Cited by 9
Conversion of a dietary fructose: new clues from the gut microbiome
Postic, C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0185-x · Cited by 8
Xia, Y., Wu, Q., Dai, H., Lv, J.-L., Liu, Y., Sun, H. J., Jiang, Y., Chang, Q., Niu, K., & Zhao, Y. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.642509 · Cited by 10
Dietary Fructose: A Literature Review of Current Evidence and Implications on Metabolic Health
Agarwal, V., Das, S., Kapoor, N., Prusty, B., & Das, B. (2024) · Cureus · doi:10.7759/cureus.74143 · Cited by 9
Cell-intrinsic insulin signaling defects in human iPS cell–derived hepatocytes in type 2 diabetes
Gattu, A. K., Tanzer, M. C., Yaron-Barir, T. M., Johnson, J. L., Jayavelu, A. K., Pan, H., Dreyfuss, J. M., Cantley, L. C., Mann, M., & Kahn, C. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci183513 · Cited by 7
Self-citationKravchuk, S., Bychkov, M. A., Kozyk, M., Strubchevska, O., & Kozyk, A. (2025) · Cureus · doi:10.7759/cureus.84803 · Cited by 8
Metadata
- Authors
- Softic, S., Cohen, D. E., & Kahn, C. R.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Kahn, C. Ronald
- Venue
- Digestive Diseases and Sciences
- Published
- 2016-02-08
- Volume
- 61
- Issue
- 5
- Pages
- 1282-1293
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- PMC
- PMC4838515
- OpenAlex
- W2286797029
- Cited by
- 709
- References
- 133
- Citations by year
- 2026: 52 · 2025: 76 · 2024: 88 · 2023: 78 · 2022: 92 · 2021: 79 · 2020: 88 · 2019: 57 · 2018: 44 · 2017: 42 · 2016: 13
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK031036, R01 DK033201, K12 HD000850, R37 DK048873, R01 DK056626, R01 DK103046)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, dietary fructose, hepatic de novo lipogenesis, high fructose corn syrup, high-fat diet, sugar-sweetened beverages, insulin resistance, SREBP-1c, endoplasmic reticulum stress, uric acid, mitochondrial fatty acid oxidation, reactive oxygen species, hepatic lipid metabolism, metabolic syndrome
- MeSH terms
- Diet, Fructose, Humans, Liver, Lipogenesis, Non-alcoholic Fatty Liver Disease, High Fructose Corn Syrup
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
